Trials / Completed
CompletedNCT01324349
Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery
A Prospective, Multi-Center, Randomized, Single-Blind Study to Compare the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medtronic - MITG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and effectiveness of Covidien's Hemostatic Patch to control bleeding during hepatic surgery. The performance of the Hemostatic Patch will be compared to Control as an adjunct to conventional hemostatic techniques.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Veriset Hemostatic Patch | Topical hemostat |
| DEVICE | Fibrin Sealant (TachoSil®) | Topical hemostat |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-03-29
- Last updated
- 2014-03-03
- Results posted
- 2012-09-12
Locations
6 sites across 3 countries: Austria, Belgium, Germany
Source: ClinicalTrials.gov record NCT01324349. Inclusion in this directory is not an endorsement.